NEW YORK (Reuters Health) – Thiazolidinedione treatment of diabetes in older adults is associated with an increased fracture risk, according to a report in the August issue of…
NEW YORK (Reuters Health) – When metformin and a sulphonylurea or a glinide fail to bring type 2 diabetes under control, adding pioglitazone may do the trick, French…
NEW YORK (Reuters Health) – High-dose N-acetylcysteine decreases the incidence of contrast-induced nephropathy, results of a meta-analysis indicate. “N-acetylcysteine has the advantages of being relatively innocuous, inexpensive, and…
NEW YORK (Reuters Health) – Giving low-dose dopamine to brain-dead donors can improve graft function after kidney transplantation, according to trial findings reported in the Journal of the…
NEW YORK (Reuters Health) – Rectal diclofenac, oral ibuprofen, and oral acetaminophen are ineffective for preventing recurrences of febrile seizures in children, new research suggests. Moreover, such agents…
NEW YORK (Reuters Health) – Imipenem-resistant Pseudomonas aeruginosa (IRPA) is an emerging problem and, in the ICU, patient-to-patient transmission may occur, even in the absence of an outbreak,…
NEW YORK (Reuters Health) – As a treatment for renal tumors, robot-assisted partial nephrectomy (RAPN) offers comparable oncologic control as traditional laparoscopic nephrectomy, but with less blood loss,…
NEW YORK (Reuters Health) – Doubling the standard dose of fluvestrant improves the efficacy of the drug against breast cancer without affecting tolerability, new research suggests. Moroever, at…
NEW YORK (Reuters Health) – Treatment with fluvastatin both before and after vascular surgery decreases the incidence of cardiovascular death and myocardial infarction, according to results of a…
NEW YORK (Reuters Health) – Adding dual antiplatelet therapy on top of existing anticoagulant therapy increases the bleeding risk after percutaneous coronary stenting, according to results from the…
